SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control

Catalog no. PC-SARSCOV2SSAF · Research Use Only

$200 per 5 applications. Ships within 2–3 business days from the U.S.

PC-SARSCOV2SSAF — affinity-purified Rabbit antibody against SARS CoV-2 Spike Glycoprotein South Africa variant. Validated for WB.

Specifications

Catalog numberPC-SARSCOV2SSAF
TargetSARS CoV-2 Spike Glycoprotein South Africa variant
ApplicationsWB
ConjugateUnconjugated
Size5 applications
Storage-20°C
UniProtP0DTC2

About this target

SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control is a Western blot positive control for SARS CoV-2 Spike Glycoprotein South Africa variant antibodies. It gives a reference band to confirm the antibody and the blotting procedure are working. Supplied for 5 applications, for research use only. [Spike protein S1]: Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2. When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane. When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis using host TFRC and GRM2 and leading to fusion of the virion membrane with the host endosomal membrane. Alternatively, may use NRP1/NRP2 and integrin as entry receptors. Subcellular location: Virion membrane; Single-pass type I membrane protein. Host endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type I membrane protein. Host cell membrane; Single-pass type I membrane protein.

Documents

Related products

FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.